Capsule Polysaccharide Mediates Bacterial Resistance to Antimicrobial Peptides
Top Cited Papers
Open Access
- 1 December 2004
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 72 (12), 7107-7114
- https://doi.org/10.1128/iai.72.12.7107-7114.2004
Abstract
The innate immune system plays a critical role in the defense of areas exposed to microorganisms. There is an increasing body of evidence indicating that antimicrobial peptides and proteins (APs) are one of the most important weapons of this system and that they make up the protective front for the respiratory tract. On the other hand, it is known that pathogenic organisms have developed countermeasures to resist these agents such as reducing the net negative charge of the bacterial membranes. Here we report the characterization of a novel mechanism of resistance to APs that is dependent on the bacterial capsule polysaccharide (CPS). Klebsiella pneumoniae CPS mutant was more sensitive than the wild type to human neutrophil defensin 1, β-defensin 1, lactoferrin, protamine sulfate, and polymyxin B. K. pneumoniae lipopolysaccharide O antigen did not play an important role in AP resistance, and CPS was the only factor conferring protection against polymyxin B in strains lacking O antigen. In addition, we found a significant correlation between the amount of CPS expressed by a given strain and the resistance to polymyxin B. We also showed that K. pneumoniae CPS mutant bound more polymyxin B than the wild-type strain with a concomitant increased in the self-promoted pathway. Taken together, our results suggest that CPS protects bacteria by limiting the interaction of APs with the surface. Finally, we report that K. pneumoniae increased the amount of CPS and upregulated cps transcription when grown in the presence of polymyxin B and lactoferrin.Keywords
This publication has 81 references indexed in Scilit:
- β-Defensin 1 Contributes to Pulmonary Innate Immunity in MiceInfection and Immunity, 2002
- Molecular Analysis of the Contribution of the Capsular Polysaccharide and the Lipopolysaccharide O Side Chain to the Virulence of Klebsiella pneumoniae in a Murine Model of PneumoniaInfection and Immunity, 2002
- How do bacteria resist human antimicrobial peptides?Trends in Microbiology, 2002
- Stages of Polymyxin B Interaction with the Escherichia coli Cell EnvelopeAntimicrobial Agents and Chemotherapy, 2000
- Complementation ofBrucella abortusRB51 with a FunctionalwboAGene Results in O-Antigen Synthesis and Enhanced Vaccine Efficacy but No Change in Rough Phenotype and AttenuationInfection and Immunity, 2000
- Capsular Polysaccharide Is a Major Complement Resistance Factor in Lipopolysaccharide O Side Chain-Deficient Klebsiella pneumoniae Clinical IsolatesInfection and Immunity, 2000
- Inactivation of the dlt Operon inStaphylococcus aureus Confers Sensitivity to Defensins, Protegrins, and Other Antimicrobial PeptidesJournal of Biological Chemistry, 1999
- PEPTIDES AS WEAPONS AGAINST MICROORGANISMS IN THE CHEMICAL DEFENSE SYSTEM OF VERTEBRATESAnnual Review of Microbiology, 1995
- How bacteria resist killing by host-defense peptidesTrends in Microbiology, 1994
- Ultrasensitive assays for endogenous antimicrobial polypeptidesJournal of Immunological Methods, 1991